Focal segmental glomerulosclerosis and Memory loss

Summary:

Memory loss is found among people with Focal segmental glomerulosclerosis, especially for people who are female, 50-59 old.

The study analyzes which people have Memory loss with Focal segmental glomerulosclerosis. It is created by eHealthMe based on reports of 17 people who have Focal segmental glomerulosclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Focal segmental glomerulosclerosis?

Focal segmental glomerulosclerosis (scar tissue that forms in parts of the kidney called glomeruli) is found to be associated with 176 drugs and 397 conditions by eHealthMe. Check the latest studies of Focal segmental glomerulosclerosis.

What is Memory loss?

Memory loss is found to be associated with 2,728 drugs and 4,376 conditions by eHealthMe. Check the latest studies of Memory loss.



On Jul, 31, 2026

17 people who have Focal Segmental Glomerulosclerosis and Memory Loss are studied.

Would you have Memory loss when you have Focal segmental glomerulosclerosis?

Gender of people who have Focal Segmental Glomerulosclerosis and experienced Memory Loss *:

  • female: 64.71 %
  • male: 35.29 %

Age of people who have Focal Segmental Glomerulosclerosis and experienced Memory Loss *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 9.09 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 9.09 %
  • 50-59: 54.55 %
  • 60+: 27.27 %

Common co-existing conditions for these people *:

  1. Nephrotic Syndrome (kidney disease with proteinuria, hypoalbuminemia, and oedema): 9 people, 52.94%
  2. Type 2 Diabetes: 2 people, 11.76%
  3. Swelling: 2 people, 11.76%
  4. Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 11.76%
  5. Nephritic Syndrome (a collection of signs (known as a syndrome) associated with disorders affecting the kidneys, more specifically glomerular disorders): 2 people, 11.76%
  6. High Blood Cholesterol: 2 people, 11.76%
  7. Glomerulonephritis Membranous (nephritis with inflammation of the capillary loops in the renal glomeruli): 2 people, 11.76%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 11.76%
  9. Bone Loss: 2 people, 11.76%
  10. Blood Pressure Abnormal: 2 people, 11.76%

Common drugs taken by these people *:

  1. Zovirax: 4 people, 23.53%
  2. Omega-3 Fatty Acids: 4 people, 23.53%
  3. Cartia Xt: 4 people, 23.53%
  4. Clopidogrel: 4 people, 23.53%
  5. Crestor: 4 people, 23.53%
  6. Nexium: 4 people, 23.53%
  7. Lyrica: 4 people, 23.53%
  8. Tradjenta: 4 people, 23.53%
  9. Tamsulosin: 4 people, 23.53%
  10. Lasix: 2 people, 11.76%

Common symptoms for these people *:

  1. Insomnia (sleeplessness): 11 people, 64.71%
  2. Depression: 9 people, 52.94%
  3. Drug Ineffective: 7 people, 41.18%
  4. Fatigue (feeling of tiredness): 7 people, 41.18%
  5. Dizziness: 6 people, 35.29%
  6. Blood Potassium Decreased: 6 people, 35.29%
  7. Weakness: 5 people, 29.41%
  8. Pain: 5 people, 29.41%
  9. Muscle Aches (muscle pain): 4 people, 23.53%
  10. Stress And Anxiety: 4 people, 23.53%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Memory loss?

- Check whether Memory loss is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Memory loss:

All the conditions that are associated with Memory loss:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Memory loss and Focal segmental glomerulosclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: